Egyptians design 'faster, cheaper' hepatitis C test

March 14, 2012

The American University in Cairo said Wednesday that a team of its researchers has designed a faster and cheaper test for all types of hepatitis C, which it says affects about 10 million Egyptians.

The development "reduces the two-step testing process carried out over a number of days to a one-step process that takes less than an hour... at a fraction of the cost of traditional diagnostic protocols," the university said.

The liquid chemistry test can diagnose using , it said.

"Our test is sensitive and inexpensive, and it does not need sophisticated equipment," said Hassan Azzazy, professor of chemistry and head of the research team.

"Detecting HCV during the first six months raises the recovery rate to 90 percent. Little is done on the national level to combat the alarming prevalence of hepatitis C in Egypt," said Azzazy.

The AUC said Egypt has about 10 million people who suffer from the (HCV), with the blood-borne pathogen infecting almost 500,000 in the country each year.

Worldwide, around 170 million people are estimated to be living with the chronic disease caused by the virus.

Unlike hepatitis A or B, most people infected with HCV cannot shake off the virus on their own because, when under attack by the immune system, it morphs into stronger variants.

The estimates that three to four million people are newly infected with HCV each year.

The WHO says Egypt has one of the highest rates of hepatitis C prevalence in the world, putting the rate of infection in the country at 22 percent.

Contamination can occur through blood transfusions, blood products and , and the virus can also be passed on to a child if the mother is infected.

Explore further: The risk factors of idiopathic pulmonary fibrosis in HCV patients

Related Stories

Pinpointing a tell-tale mark of liver cancer

July 8, 2011

Persistent hepatitis C virus (HCV) infection can lead to chronic hepatitis C and then progress to fatal liver diseases including liver cirrhosis and liver cancer, the third most common cause of cancer-related deaths. Worldwide, ...

New vaccine for hepatitis C virus

July 28, 2011

Murdoch University researchers have begun a study to develop a new and innovative vaccine for the hepatitis C virus (HCV).

Recommended for you

New drug to fight fatal but neglected tropical disease

August 31, 2016

In a breakthrough for those infected by the parasites that cause sleeping sickness, a young Queensland researcher has identified a compound that kills the parasites in the lab without having any toxic effect on human cells.

Traces of Ebola virus linger longer than expected in semen

August 31, 2016

Initial data from a Liberian public health program show about 9 percent (38) of 429 male Ebola survivors had fragments of Ebola virus in their semen. Of those, 63 percent had semen samples that tested positive for Ebola fragments ...

Researchers discover a drug for a tropical disease

August 30, 2016

Researchers at the University of Georgia are working to find the fastest way possible to treat and cure human African trypanosomiasis, long referred to as sleeping sickness. By working to improve chemical entities already ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.